Medical Condition News

RSS

New study finds treatment-resistant epilepsy common in idiopathic autism

A new study found that treatment-resistant epilepsy (TRE) is common in idiopathic autism. Early age at the onset of seizures and delayed global development were associated with a higher frequency of resistance to antiepileptic drugs (AEDs). Full findings appear online in Epilepsia, a journal published by Wiley-Blackwell on behalf of the International League Against Epilepsy (ILAE).

19 Apr 2011

DaVita re-designs its leading online kidney disease resource

DaVita Inc., a leading provider of kidney care services for those diagnosed with end stage renal disease and chronic kidney disease, today announced the redesign and launch of DaVita.com, the leading online resource for information about kidney disease.

19 Apr 2011

Journal of Clinical Oncology publishes CytRx tamibarotene Phase 2b trial results in APL

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced the publication of a case report in the peer-reviewed Journal of Clinical Oncology documenting the use of tamibarotene in the successful treatment of a patient with recurrent advanced-stage acute promyelocytic leukemia.

19 Apr 2011

Researchers investigate new digital tool for breast cancer prognosis

Cancer researchers at the University of Calgary are investigating a new tool to use for the prognosis of breast cancer in patients. This new digital tool will help give patients a more accurate assessment of how abnormal and aggressive their cancer is and help doctors recommend the best treatment options.

19 Apr 2011

Anti-depressants spur creation and survival of new brain cells after brain injury

Anti-depressants may help spur the creation and survival of new brain cells after brain injury, according to a study by neurosurgeons at the University of Rochester Medical Center.

19 Apr 2011

First bypass surgery to restore lost brain tissue performed at Krembil Neuroscience Centre

Neurosurgeons at the Krembil Neuroscience Centre, Toronto Western Hospital, have for the first time, initiated the restoration of lost brain tissue through brain bypass surgery in patients where blood flow to the brain is impaired by cerebrovascular disease. The study, which involved 29 patients, was published online in the journal Stroke.

19 Apr 2011

Drospirenone doesn't carry any risk of gall bladder disease

Drospirenone, the top-selling oral contraceptive marketed as Yaz or Yasmin in the U.S. and Canada, doesn't carry any more risk of gall bladder disease than the older generation of birth control pills, despite claims by some consumers and lawyers in both countries, according to a new study by University of British Columbia and Vancouver Coastal Health Research Institute researcher Mahyar Etminan.

19 Apr 2011

HHWC introduces Executive Edge Wellness Program

Hotze Health & Wellness Center, a world leader in the alternative health care industry, today announced the launch of its newly created Executive EdgeTM Wellness Program.

19 Apr 2011

FDA approves Taro's Imiquimod Cream ANDA

Taro Pharmaceutical Industries Ltd. reported today that it has received approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for Imiquimod Cream, 5%.

19 Apr 2011

Roche introduces new EMR interface for the U.S. Department of VA

Roche announced today that it has introduced a new Electronic Medical Record interface for the U.S. Department of Veterans Affairs that helps VA healthcare facilities improve their efficiency and accuracy by transmitting patient diabetes management data directly into the VistA computerized patient record system.

From Roche Sequencing and Life Science 19 Apr 2011

Japan Tobacco and Torii commence ferric citrate Phase 3 clinical program for hyperphosphatemia

Keryx Biopharmaceuticals, Inc., announced today that its Japanese partner, Japan Tobacco Inc. (JT) and Torii Pharmaceutical Co., Ltd., JT's pharmaceutical business subsidiary, has commenced the Phase 3 clinical program of ferric citrate in Japan for the treatment of patients with hyperphosphatemia.

18 Apr 2011

Tweaking gene in satellite cells may increase lifespan of people with muscular dystrophy

Researchers have long questioned why patients with Duchenne muscular dystrophy (DMD) tend to manage well through childhood and adolescence, yet succumb to their disease in early adulthood, or why elderly people who lose muscle strength following bed rest find it difficult or impossible to regain.

18 Apr 2011

Non-alcoholic fatty liver disease linked to coronary artery disease

Because of the prevalence of obesity in our country, many Americans are expected to develop a serious condition called non-alcoholic fatty liver disease (NAFLD), which can lead to cirrhosis, fibrosis, and in some cases liver failure. It is also one of the best predictors for coronary artery disease.

18 Apr 2011

Novel lifestyle program may slow loss of brain cells due to aging and also grow new cells

In March, more than 80 residents at Emeritus at Ocoee, an assisted living and memory care community in Central Florida, began a new and highly promising research-based Brain Health Lifestyle Program which was designed to not only slow the loss of brain cells due to aging, but also grow new cells.

18 Apr 2011

St. Jude Medical's Accent MRI pacemaker and Tendril MRI lead system receives European CE Mark approval

St. Jude Medical, Inc., a global medical device company, today announced that it has received European CE Mark approval for its Accent MRI™ pacemaker and Tendril MRI™ lead. The system, designed and tested for safe use in a Magnetic Resonance Imaging (MRI) environment and approved as MR-Conditional, allows patients to undergo full-body, high-resolution MRI scans.

18 Apr 2011

FDA accepts Regeneron's VEGF Trap-Eye BLA for review

Regeneron Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has accepted for review the Company's Biologics License Application for VEGF Trap-Eye for the treatment of the neovascular form of age-related macular degeneration.

18 Apr 2011

Biotech Synergy concludes EP-2101 asset transfer, cancer epitopes related portfolio

Biotech Synergy has concluded the asset transfer of multi-epitope cancer vaccine product formerly known as EP-2101 and cancer epitopes related portfolio. Emile Loria, M.D., former President and Chief Business Officer of IDM and former President & CEO of Epimmune, is the founder of Biotech Synergy.

18 Apr 2011

Medical Condition News

New study finds treatment-resistant epilepsy common in idiopathic autism

DaVita re-designs its leading online kidney disease resource

Journal of Clinical Oncology publishes CytRx tamibarotene Phase 2b trial results in APL

Researchers investigate new digital tool for breast cancer prognosis

Anti-depressants spur creation and survival of new brain cells after brain injury

First bypass surgery to restore lost brain tissue performed at Krembil Neuroscience Centre

Drospirenone doesn't carry any risk of gall bladder disease

HHWC introduces Executive Edge Wellness Program

FDA approves Taro's Imiquimod Cream ANDA

Roche introduces new EMR interface for the U.S. Department of VA

Japan Tobacco and Torii commence ferric citrate Phase 3 clinical program for hyperphosphatemia

Tweaking gene in satellite cells may increase lifespan of people with muscular dystrophy

Non-alcoholic fatty liver disease linked to coronary artery disease

Novel lifestyle program may slow loss of brain cells due to aging and also grow new cells

St. Jude Medical's Accent MRI pacemaker and Tendril MRI lead system receives European CE Mark approval

FDA accepts Regeneron's VEGF Trap-Eye BLA for review

Biotech Synergy concludes EP-2101 asset transfer, cancer epitopes related portfolio

Top-line results from Amarin's AMR101 Phase 3 trial in patients with high triglycerides

Ipsen, Active Biotech sign deal to co-develop and commercialize TASQ

Scientists develop new compound for multiple sclerosis treatment

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News